Psychedelic Stocks,Shroom News Lobe Sciences Appoints Charles Grob to Scientific Advisory Board By Dennis Mutua June 30, 2021 Life sciences company focused on research and development of psychedelic medicines Lobe Sciences Ltd (CSE: LOBE) (OTCMKTS: GTSIF) announced having appointed Charles S. Grob, to the scientific advisory board of the company. Cher...
Psychedelic Stocks,Shroom News MindMed Added to the FTSE Russell 3000® Index By Dennis Mutua June 29, 2021 Psychedelic medicine biotech company specializing developing and deploying psychedelic inspired medicine MindMed Inc. (MMED) announced having been added to the FTSE Russell 3000® Index with effect from June 25, 2021. The FTSE ...
Psychedelic Stocks,Shroom News Numinus Wellness Files Patent Application for Psychedelic Fungi Extraction Process By Dennis Mutua June 28, 2021 Wellness company providing solutions to deliver psychedelic-assisted therapy and transform the mental health landscape Numinus Wellness Inc. (CVE: NUMI) announced having filed a provisional patent application for a psychedelic fun...
Psychedelic Stocks,Shroom News Wesana Enters Into a Research Partnership With University of South Carolina By Dennis Mutua June 25, 2021 Life Sciences company championing development and delivery of psychedelics and naturally-extracted therapies to treat brain injuries Wesana Health Holdings Inc. (CNSX: WESA) announced having entered in a partnership with the Unive...
Featured,Shroom News Senator Scott Wiener Interviewed by Global Trac to Discuss Psychedelics Legalization By Dennis Mutua June 24, 2021 Digital media company focusing on the emerging psychedelics medicine industry aiming to transform the world of mental health treatments Global Trac Solutions Inc. (OTCPink: PSYC) interviewed California Senator, Scott Wiener, regar...
Shroom News Cybin Completes its 51st Pre-clinical Psychedelic Molecule Study By Dennis Mutua June 23, 2021 Biopharmaceutical company specializing in advancing psychedelic therapeutic Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) announced having completed its 51st pre-clinical psychedelic molecule study. The company now continues to progres...
Psychedelic Stocks,Shroom News Atai Life Sciences Becomes Third Psychedelics Company to Get Listed on NASDAQ By Dennis Mutua June 22, 2021 Clinical stage bio-pharmaceutical company aiming to transform treatment of mental conditions and disorders Atai Life Sciences BV (ATAI) made history as the third psychedelics company to get listed on the NASDAQ stock exchange mark...
Psychedelic Stocks,Shroom News Numinus Wellness Receives Approval To Graduate to Tier 1 on TSX Venture Exchange By Dennis Mutua June 21, 2021 Life wellness company providing solutions to develop and deliver psychedelics-assisted psychotherapy and transform mental health landscape Numinus Wellness Inc. (TSVX: NUMI) announced having received an approval to graduate to tie...